Banner for leaf pages 2


Also known as Micronase and Diabeta

Glibenclamide (INN), also known as glyburide (USAN), is an antidiabetic drug in a class of medications known as sulfonylureas, closely related to sulfa drugs. It was developed in 1966 in a cooperative study between Boehringer Mannheim (now part of Roche) and Hoechst (now part of Sanofi-Aventis).

Source: Wikipedia

Estimated Total Cost: $11.61 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed glyburide to treat diabetes, gestational diabetes, diabetic peripheral neuropathy, and thirst.

Ajax-loader Loading...